Reduction of EGF receptor levels in human tumor cells transfected with an antisense RNA expression vector.
An expression vector was constructed from part of pSV2neo with the 3'-ClaI fragment of the epidermal growth factor (EGF) receptor cDNA inserted in an inverted orientation downstream from the human metallothionein (MT) IIa promoter. The human squamous carcinoma cell line NA, which overproduces EGF receptor, was transfected with this vector and selected for resistance to the neomycin derivative G418. One of the stable transfectants had a 90% reduction in cell-surface EGF receptor in response to ZnSO4. The nascent EGF receptor peptide was also decreased with concurrent induction of MT mRNA. These data suggest that the antisense transcript regulated by the MT promoter inhibits the expression of the endogenous EGF receptor genes. Although no transcripts from the antisense gene were detected, the results indicate that transfection with the antisense vector provides a technique by which to modulate the number of EGF receptors on the cell surface of squamous cell carcinomas.
Yamada
H
H
National Institute of Industrial Health, Kawasaki, Japan.
Koizumi
S
S
Kimura
M
M
Shimizu
N
N
D015152:Blotting, Northern; D015139:Blotting, Southern; D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D003001:Cloning, Molecular; D004815:Epidermal Growth Factor / Q000378:metabolism*; D066246:ErbB Receptors / Q000378:metabolism*; D005784:Gene Amplification; D015972:Gene Expression Regulation, Neoplastic; D052138:Genes, Neoplasm; D005822:Genetic Vectors; D006801:Humans; D008668:Metallothionein / Q000235:genetics; D012313:RNA; D016372:RNA, Antisense; D012334:RNA, Neoplasm; D014407:Tumor Cells, Cultured; D015032:Zinc / Q000494:pharmacology
D016372:RNA, Antisense; D012334:RNA, Neoplasm; D004815:Epidermal Growth Factor; D012313:RNA; D008668:Metallothionein; D066246:ErbB Receptors; D015032:Zinc